Abstract
Interleukin 2 (IL-2), one of the first lymphokines to be identified, plays a major role in the clonal expansion of T lymphocytes (T cells) by interacting with specific cell surface receptors (IL-2 receptors; Morgan et al. 1976; Smith 1984,1988; Taniguchi et al. 1986 a). Expression of both IL-2 and IL-2 receptor requires T cell activation, triggered primarily by the interaction of the antigen/MHC molecules: T cell receptor complex (CD3/Ti complex). Hence, in effect, clonal proliferation of antigen-specific T cells appears to occur via a process of signal transduction, wherein the specific interaction of antigen/MHC and the T cell receptor complex is converted into a pathway of cellular growth through the operation of the IL-2 system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Altman A, Cardenas JM, Houghten RA, Dixon FJ, Theofilopoulos AN (1984) Antibodies of predetermined specificity against chemically synthesized peptides of human interleukin 2. Proc Natl Acad Sei USA 81:2176–2180.
Arima N, Daitoku Y, Yamamoto Y, Fujimoto K, Ohgaki S, Kojima K, Fukumori J, Matsushita K, Tanaka H, Onoue K (1987) Heterogeneity in response to interleukin 2 and interleukin 2-producing ability of adult T cell leukemic cells. J Immunol 138:3069–3074.
Arya SK, Wong-Staal F, Gallo RC (1984) T-cell growth factor gene: lack of ex-pression in human T-cell leukemia-lymphoma virus-infected cells. Science 223: 1086–1087.
Bacha P, Williams DP, Waters C, Williams JM, Murphy JR, Storm TB (1988) Inter-leukin 2 receptor-targeted cytotoxity. J Exp Med 167:612–622.
Ballard DW, Bohnlein E, Lowenthal JW, Wano Y, Franza BR, Greene WC (1988) HTLV-I tax induces cellular proteins that activate the NFKB element in the IL-2 receptor a-gene. Science 241:1652–1655.
Benveniste EN, Merrill JE (1986) Stimulation of oligodendrogrial proliferation and maturation by interleukin-2. Nature 321:610–613.
Bohnlein E, Lowenthal JW, Siekevitz M, Ballard DW, Franza BR, Greene WC (1988) The same inducible nuclear protein regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV. Cell 53:827–836.
Brandhuber BJ, Boone T, Kenney WC, McKay DB (1987) Three-dimentional structure of interleukin-2. Science 238:1707–1709.
Cantrell DA, Smith KA (1983) Transient expression of interleukin 2 receptors. Consequences for T cell growth. J Exp Med 158:1895–1911.
Cerretti DP, McKereghan K, Larsen A, Cantrell MA, Anderson D, Gillis S, Cosman D, Baker PE (1986) Cloning sequence and expression of bovine interleukin 2. Proc Natl Acad Sei USA 83:3223–3227.
Cosman D, Ceretti DP, Larsen A, Park L, March C, Dower S, Gillis S, Urdal D (1984) Cloning, sequence and expression of human interleukin-2 receptor. Nature 312:768–771.
Cross SL, Feinberg MB, Wolf JB, Holbroch NJ, Wong-Staal F, Leonard WJ (1987) Regulation of the human interleukin-2 receptor a chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-1. Cell 49:47–56.
Doi T, Hatakeyama M, Itoh S, Taniguchi T (1989) Transient induction of IL-2 receptor in cultured T cell lines by HTLV-1 LTR-linked tax-1 gene. EMBO J 8:1953–1958.
Dukovich M, Wano Y, Thuy JB, Katz P, Cullen BR, Kehrl JH, Greene WC (1987) A second human interleukin-2 binding protein that may be a component of high- affinity interleukin-2 receptors. Nature 327:518–522.
Durand DB, Bush MR, Margan JG, Weiss A, Crabtree GR (1987) A 275 base pair fragment at the 5’ end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor. J Exp Med 165:395–407.
Durand DB, Shaw J-P, Bush MR, Replogle RE, Belagaje R, Crabtree GR (1988) Characterization of antigen receptor, response elements with the interleukin-2 enhancer. Mol Cell Biol 8:1715–1724.
Efrat S, Pilo S, Kaempfer R (1982) Kinetics of induction and molecular size of mRNAs encoding human interleukin-2 and y-interferon. Nature 297:236–239.
Evans SW, Beckner SK, Farrar WL (1987) Stimulation of specific GTP binding and hydrolysis activities in lymphocyte membrane by interleukin-2. Nature 325:166–168.
Farrar WL, Anderson WB (1985) Interleukin-2 stimulates association of protein kinase C with plasma membrane. Nature 315:233–235.
Felber BK, Paskalis H, Kleinman-Ewing C, Wong-Staal F, Pavlakis G (1985) The pX protein of HTLV-1 is a transcriptional activator of its long terminal repeats. Science 229:675–679.
Flexner C, Hugin A, Moss B (1987) Prevention of Vaccinia virus infection in im-munodeficient mice by vector-directed IL-2 expression. Nature 330:259–262.
Fujii M, Sugamura K, Sano K, Nakai M, Sugita K, Hinuma Y (1986) High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells. J Exp Med 163:550–562.
Fujisawa J, Seiki M, Kiyokawa T, Yoshida M (1985) Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor. Proc Natl Acad Sci USA 82:2277–2281.
Fujita T, Takaoka C, Matsui H, Taniguchi T (1984) Structure of the human interleukin 2 gene. Proc Natl Acad Sci USA 80:7437–7441.
Fujita T, Shibuya H, Ohashi K, Yamanishi K, Taniguchi T (1986) Regulation of human interleukin-2 gene: functional DNA sequences in the 5’ flanking region for the gene expression in activated T lymphocytes. Cell 46:401–407.
Fuse A, Fujita T, Yasumitsu N, Kashima N, Hasegawa K, Taniguchi T (1984) Organization and structure of the mouse interleukin-2 gene. Nucleic Acids Res 12:9323–9331.
Gootenberg JE, Ruscetti FW, Mier JW, Gazdar A, Gallo RC (1981) Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor. J Exp Med 154:1403–1418.
Greene WC, Leonard WC (1986) The human interleukin-2 receptor. Annu Rev Immunol 4:69–96.
Greene WC, Robb RJ, Svetlik PB, Rusk CM, Depper JM, Leonard WJ (1985) Stable expression of cDNA encoding the human interleukin-2 receptor in eukaryotic cells. J Exp Med 162:363–368.
Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155:1823–1841.
Hatakeyama M, Minamoto S, Uchiyama T, Hardy RR, Yamada G, Taniguchi T (1985) Reconstitution of functional receptor for human interleukin-2 in mouse cells. Nature 318:467–470.
Hatakeyama M, Minamoto S, Taniguchi T (1986) Intracytoplasmic phosphorylation sites of Tac antigen (p55) are not essential for the conformation, function, and regulation of the human interleukin 2 receptor. Proc Natl Acad Sci USA 83:9650–9654.
Hatakeyama M, Doi T, Kono T, Maruyama M, Minamoto S, Mori H, Kobayashi H, Uchiyama T, Taniguchi T (1987) Transmembrane signaling of interleukin 2 recep-tor: conformation and function of human interleukin 2 receptor (p55)/insulin recep-tor chimeric molecules. J Exp Med 166:362–375.
Hatakeyama M, Tsudo M, Minamoto S, Kono T, Doi T, Miyata T, Miyasaka M, Taniguchi T (1989) Interleukin-2 receptor β chain gene: generation of three receptor forms by cloned human a and β chain cDNA’s. Science 244:551–556.
Hattori T, Uchiyama T, Toibana T, Takatsuki K, Uchino H (1981) Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies. Blood 58:645–647.
Henny CS, Kuribayashi K, Kern DE, Gillis S (1981) Interleukin-2 augments natural killer cell activity. Nature 291:335–338.
Herrmann T, Diamantstein T (1988) The human intermediate-affinity interleukin 2 receptor consists of two distinct, partially homologous glycoproteins. Eur J Immunol 18:1051–1057.
Holbrook NJ, Smith KA, Fornace AJ, Comeau CM, Wiskocil RL, Crabtree GR (1984) T-cell growth factor: complete nucleotide sequence and organization of the gene in normal and malignant cells. Proc Natl Acad Sci USA 81:1634–1638.
Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M (1986) Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type I. EMBO J 5:2883–2888.
Ishida N, Kanamori H, Noma T, Nikaido T, Sabe H, Suzuki N, Shimizu A, Honjo T (1985) Molecular clonig and structure of the human interleukin-2 receptor gene. Nucleic Acids Res 13:7579–7589.
Ju G, Collins L, Kaffka KL, Tsien W-H, Chizzonite R, Crowl R, Bhatt R, Kilian PL (1987) Structure-function analysis of human interleukin-2. J Biol Chem 262:5723–5731.
Jung LKL, Hara T, Fu SM (1984) Detection and functional studies of p60–65 (Tacantigen) on activated human B cells. J Exp Med 160:1597–1602.
Kashima N, Nishi-Takaoka C, Fujita T, Taki S, Yamada G, Hamuro J, Taniguchi T (1985) Unique structure of murine interleukin-2 as deduced from cloned cDNAs. Nature 313:402–404.
Kelley VE, Gaulton GN, Hattori M, Ikegami H, Eisenbarth G, Strom TB (1988) Anti- interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis. J Immunol 140:59–61.
Kirkman RL, Barrett LV, Gaulton GN, Kelly VE, Ythier A, Strom TB (1985) Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice. J Exp Med 162:358–362.
Kiyokawa T, Seiki M, Iwashita S, Imagawa K, Shimizu F, Yoshida M (1985) p27x-IIIin and p21x-IIIm proteins encoded by pX sequence of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 82:8359–8363.
Kondo S, Shimizu A, Maeda M, Tagaya A, Yodoi J, Honjo T (1986) Expression of functional human interleukin-2 receptor in mouse T cells by cDNA transfection. Nature 320:75–77.
Kondo S, Kinoshita M, Shimizu A, Saito Y, Konishi M, Sabe H, Honjo T (1987) Ex-pression and functional characterization of artificial mutants of interleukin-2 recep-tor. Nature 327:64–67.
Koyasu S, Yodoi J, Nikaido T, Tagaya Y, Taniguchi Y, Honjo T, Yahara I (1986) Expression of interleukin 2 receptors on interleukin 3 dependent cell lines. J Immunol 136:984–987.
Kuo L-M, Robb RJ (1986) Structure-function relationships for the IL-2 receptor system I. Localization of a receptor binding site on IL-2. J Immunol 137:1538–1543.
LeGrue SJ (1988) Does interleukin 2 stimulus-response coupling result in generation of intracellular second messengers? Lymphokine Res 7:187–200.
Leonard WJ, Depper JM, Uchiyama T, Smith KA, Waldmann TA, Greene WC (1982) A monoclonal antibody that appears to recognize the receptor for human T cell growth factor; partial characterization of the receptor. Nature 300:267–269.
Leonard WJ, Depper JM, Crabtree GR, Rudikoff S, Pumphrey J, Robb RJ, Svetlik PB, Peffer N, Waldmann TA, Greene WC (1984) Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 311:626–631.
Leonard WJ, Depper JM, Kanehisa M, Kronke M, Peffer N, Svetlik PB, Sullivan M, Greene WC (1985) Structure of the human interleukin-2 receptor gene. Science 230:633–639.
Leung K, Nabel GJ (1988) HTLV-1 transactivator induces interleukin-2 receptor ex-pression through an NF-kB-like factor. Nature 333:776–778.
Lotze MT, Grimm EA, Mazumder A, Strausser SA, Rosenberg SA (1981) Lysis of fresh and cultured autologous tumor by lymphocytes cultured in T-cell growth factor. Cancer Res 41:4420–4425.
Malkovsky M, Loveland B, North M, Asherson GL, Gao L, Ward P, Fiers W (1987) Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature 325:262–264.
Maruyama M, Shibuya H, Harada H, Hatakeyama M, Seiki M, Fujita T, Inoue J-I, Yoshida M, Taniguchi T (1987) Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering. Cell 48:343–350.
Mills GB, Stewart DJ, Mellors A, Gelfand EW (1986) Interleukin 2 does not induce phosphatidylinositol hydrolysis in activated T cells. J Immunol 136:3019–3024.
Mills GB, Girard P, Grinstein S, Gelfand EW (1988) Interleukin-2 induces proliferation of T lymphocyte mutants lacking protein kinase C. Cell 55:91–100.
Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuka Y, Shiraishi Y, Nagata K, Hinuma Y (1981) Type C virus particles in a cord T-cell line derived by co- cultivating normal human cord leukocytes and human leukemic T cells: Nature 294:770–771.
Morgan DA, Ruscetti FW, Gallo RC (1976) Selective in vitro growth of T-lymphocytes from normal human bone marrows. Science 193:1007–1008.
Nabel G, Baltimore D (1987) An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326:711–713.
Nabel GJ, Gorka C, Baltimore D (1988) T-cell specific expression of interleukin 2: evidence for a negative regulatory site. Proc Natl Acad Sei USA 85:2934–2938.
Nikaido T, Shimizu A, Ishida N, Sabe H, Teshigawara K, Maeda M, Uchiyama T, Yodoi J, Honjo T (1984) Molecular cloning of cDNA encoding human interleu- kin-2 receptor. Nature 311:631–635.
Perentesis JP, Genbauffe FS, Veldman SA, Galeotti GL, Livingston DM, Bodley JM, Murphy J (1988) Expression of diphtheria toxin fragment A and hormone-toxin fusion proteins in toxin-resistant yeast mutants. Proc Natl Acad Sei USA 85:8386–8390.
Ramshaw IA, Andrew ME, Phillips SM, Boyle DB, Coupar BEH (1987) Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection. Nature 329:545–546.
Reed JC, Sabath DE, Hoover RG, Prystowsky MB (1985) Recombinant interleukin-2 regulates levels of c-myc mRNA in a cloned murine T lymphocytes. Mol Cell Biol 5:3361–3368.
Reeves R, Spies AG, Nissen MS, Buck CD, Weingerg AD, Barr PJ, Magnuson NS, Magnuson JA (1986) Molecular cloning of a functional bovine interleukin 2 cDNA. Proc Natl Acad Sei USA 83:3228–3232.
Robb RJ (1986) Conversion of low-affinity interleukin 2 receptors to a high-affin-ity state following fusion of cell membranes. Proc Natl Acad Sei USA 83:3992–3996.
Robb RJ, Greene WC, Rusk CM (1984) Low and high affinity cellular receptors for interleukin-2. Implications for the level of Tac antigen. J Exp Med 154:1455–1474.
Rosenberg SA, Spiess P, Lafreniere R (1986) A new approach to the adoptive im-munotheraphy of cancer with tumor-infiltrating lymphocytes. Science 233:1318–1321.
Rosenberg SA (1988) The development of new immunotherapies for the treatment of cancer using interleukin-2. Ann Surg 208:121–135.
Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DE (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316:889–897.
Saragivo H, Malek T (1987) The murine interleukin2 receptor: irreversible cross- linking of radiolabeled interleukin 2 to high-affinity interleukin 2 receptors reveals a noncovalently associated subunit. J Immunol 139:1918–1926.
Seigel LJ, Harper ME, Wong-Staal F, Gallo RC, Nash WG, O’Brien SJ (1984) Gene for T-cell growth factor: location on human chromosome 4q and feline chromosome B1. Science 223:175–178.
Seiki M, Hattori S, Hirayama Y, Yoshida M (1983) Human adult T-cell leukemia virus: complete nucleotide sequence of the pro virus genome integrated in leukemia cell DNA. Proc Natl Acad Sci USA 80:3618–3622.
Sharon M, Klausner RD, Cullen BR, Chizzonite R, Leonard WJ (1986) Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science 234:859–863.
Shaw J-P, Utz-PJ, Durand DB, Toole J J, Emmel EA, Crabtree GR (1988) Identification of a putative regulator of early T cell activation genes. Science 241:202–205.
Shibuya H, Yoneyama M, Taniguchi T (1989) Involvement of a common transcription factor in the regulated expression of IL-2 and IL-2 receptor genes. Int Immunol 1:43–49.
Siebenlist U, Durand DB, Bressler P, Holbrook NJ, Norris CA, Kamoun M, Kant JA, Crabtree GR (1986) Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chroramphenicol acetyltransferase gene during activation of T cells. Mol Cell Biol 6:3042–3049.
Smith KA (1984) Interleukin 2. Annu Rev Immunol 2:319–333.
Smith KA (1988) Interleukin 2: inception, impact and implications. Science 240:1169–1176.
Sodroski JG, Rosen CA, Haseltine WA (1984) Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 225:381–385.
Steiner G, Tschachler E, Tani M, Malek TR, Shevach EM, Holter W, Knapp W, Wolff K, Stingl G (1986) Interleukin 2 receptors on cultured murine epidermal Langer- hans cells. J Immunol 137:155–159.
Stern JB, Smith KA (1986) Interleukin-2 induction of T-cell G1 progression and c-myb expression. Science 233:203–206.
Sugamura K, Nakai S, Fujii M, Hinuma Y (1985) Interleukin-2 inhibits in vitro growth of human T cell lines earring retrovirus. J Exp Med 161:1243–1248.
Suzuki N, Matsunami N, Kanamori H, Ishida N, Shimizu A, Yaoita Y, Nikaido T, Honjo T (1987) The human IL-2 receptor gene contains a positive regulatory element that functions in cultured cells and cell-free extracts. J Biol Chem 262:5079–5086.
Taniguchi T (1988) Regulation of cytokine gene expression. Annu Rev Immunol 6:439–464.
Taniguchi T (1989) Structure and regulation of the genes operating in type IIFN and IL-2 systems. In: Yamamura Y (ed) Recent progress in cytokine research. Medical View, Tokyo, pp 75–88.
Taniguchi T, Matsui H, Fujita T, Takaoka C, Kashima N, Yoshimoto R, Hamuro J (1983) Structure and expression of a cloned cDNA for human interleukin-2. Nature 302:305–310.
Taniguchi T, Matsui H, Fujita T, Hatakeyama M, Kashima N, Fuse A, Hamuro J (1986 a) Molecular analysis of the interleukin-2 system. Immunol Rev 92: 121–133.
Taniguchi T, Fujita T, Hatakeyama M, Mori H, Matsui H, Sato T, Hamuro J, Minamoto S, Yamada G, Shibuya H (1986 b) Interleukin-2 and its receptor: structure and functional expression of the genes. Cold Spring Harbor Symp Quant Biol 51:577–586.
Teshigawara K, Wang H-M, Kato K, Smith KA (1987) Interleukin2 high-affinity receptor expression requires two distinct binding proteins. J Exp Med 165:223–238.
Tsudo M, Kozak RW, Goldman CK, Waldmann TA (1986) Demonstration of a non- Tac peptide that binds interleukin 2: a potential participant in a multi-chain inter- leukin 2 receptor complex. Proc Natl Acad Sci USA 83:9694–9698.
Uchiyama T, Broder S, Waldmann TA (1981) A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac(+) cells. J Immunol 126:1393–1387.
Valge VE, Wong JGP, Datlof BM, Sinskey AJ, Rao A (1988) Protein kinase C is required for responses to T cell receptor ligands but not to interleukin-2 in T cells. Cell 55:101–112.
Waldmann TA, Goldman CK, Robb RJ, Depper JM, Leonard WJ, Sharrow SO, Bongiovanni KF, Korsmeyer SJ, Greene WC (1984) Expression of interleukin 2 receptors on activated human B cells. J Exp Med 160:1450–1466.
Wang H-M, Smith KA (1987) The interleukin 2 receptor. Functional consequences of its bimolecular structure. J Exp Med 166:1055–1069.
Weiss A, Imboden J, Hardy K, Manger B, Terhost C, Stobo J (1986) The role of the T3/antigen receptor complex in T-cell activation. Annu Rev Immunol 4:593–620.
Weissman AM, Harford JB, Svetlik PB, Leonard WJ, Depper JM, Waldmann TA, Greene WC, Klausner RD (1986) Only high-affinity receptors for interleukin 2 mediate internalization of ligand. Proc Natl Acad Sci USA 83:1463–1466.
Wong-Staal F, Gallo RC (1985) Human T-lymphotropic retroviruses. Nature 317:395–403.
Yamada G, Kitamura Y, Sonoda H, Harada H, Taki S, Mulligan RC, Osawa H, Diamantstein T, Yokoyama S, Taniguchi T (1987) Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity. EMBO J 6:2705–2709.
Yokota T, Arai N, Lee F, Rennick D, Mosmann T, Arai K (1986) Use of a cDNA expression vector for isolation of mouse interleukin 2 cDNA clones: expression of T- cell growth factor activity after transfection of monkey cells. Proc Natl Acad Sci USA 82:68–72.
Yoshida M, Seiki M (1987) Recent advances in the molecular biology of HTLV-1: trans-activation of viral and cellular genes. Annu Rev Immunol 5:541–560.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Hatakeyama, M., Taniguchi, T. (1991). Interleukin-2. In: Sporn, M.B., Roberts, A.B. (eds) Peptide Growth Factors and Their Receptors I. Springer Study Edition. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3210-0_10
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3210-0_10
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-97729-4
Online ISBN: 978-1-4612-3210-0
eBook Packages: Springer Book Archive